9. Fractyl Laboratories
Venture capital raised: $38.38 million
Fractyl Laboratories raised $38.38 million for the later stage of its development during the third quarter of 2017, MoneyTree reports. This is the company’s fifth investment sequence. Venture capital investors include Allen & Co., Bessemer Venture Partners, Domain Associates and Mithril Capital Management.
Fractyl Laboratories is developing Revita DMR. The Revita DMR is a same-day, minimally-invasive procedure that treats type 2 diabetes and NAFLD/NASH.